Tag Archives: calcium channel blockers
September 2014 Br J Cardiol 2014;21:90
Correspondence: gender and outcome from acute myocardial infarction and secondary stroke
Professor Ivy Shiue; Dr Krasimira Hristova; Professor Jagdish Sharma
Dear Sirs, Research on sex difference in mortality after myocardial infarction (MI) since the 1990s has been debated and increased. Several observational studies have shown that younger women, in particular, seemed to have higher mortality rates than men of similar age during the two-year or longer follow-up, although these studies were mainly from the USA.1-3 Recent American studies have also found that, even after full adjustment for potential risk factors, excess risk for in-hospital mortality for women was still noted, particularly among those <50 years old with acute ST-segment elevation MI, leading to 98% (odds ratio [OR] 1.98, 95% c
January 2009 Br J Cardiol 2009;16(Suppl 1):S13-S14
Future of PAH: what does success look like?
BJCardio editorial team
Table 1: Emerging issues in pulmonary arterial hypertension (PAH) A likely first step might be to understand new targets. Evidence to guide clinical decision-making in how to measure success is coming from RCTs, but sometimes it can be difficult to translate this evidence into clinical experience. Professor Vachiéry discussed some of these new targets and investigational therapies, including vasoactive intestinal peptide (VIP)8 and antiproliferative agents.9 As cancer and PAH may share similar pathophysiology of aberrant cell proliferation, growth factor inhibition could play a role in the treatment of PAH, said Professor Vachiéry. But thes
October 2002 Br J Cardiol 2002;9:539-45
Revascularisation and beyond
Wiek H van Gilst, Freek WA Verheugt, Felix Zijlstra, William E Boden
No content available
For healthcare professionals only
